Clinical Trials Directory

Trials / Unknown

UnknownNCT03388996

Pelvic Microbiomes of Benign and Malignant Ovarian Diseases

The Role of Pelvic Microbiomes During the Malignant Transformation of Benign Ovarian Diseases

Status
Unknown
Phase
Study type
Observational
Enrollment
40 (estimated)
Sponsor
Lei Li · Academic / Other
Sex
Female
Age
Healthy volunteers
Not accepted

Summary

This case-control study aims to compare the pelvic microbiomes of benign ovarian diseases and ovarian malignancies by 16s RNA techniques and culture. Discharges/flushing fluid from vagina, faces and fimbria end of fallopian tube are collected from age and menopausal status matched patient before and during procedures of laparoscopies. The discharges/flushing fluid would be sent for 16s RNA analysis and microculture respectively, and the results would get self-contrasted comparison and case-control comparison.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTmicrobiomes16s RNA analysis and microculture of discharges/flushing fluid from vagina, faces and fimbria end of fallopian tube

Timeline

Start date
2018-01-01
Primary completion
2020-01-01
Completion
2021-01-01
First posted
2018-01-03
Last updated
2018-11-14

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03388996. Inclusion in this directory is not an endorsement.

Pelvic Microbiomes of Benign and Malignant Ovarian Diseases (NCT03388996) · Clinical Trials Directory